Annual Current Liabilities:
$47.40M+$26.12M(+122.80%)Summary
- As of today, PTGX annual current liabilities is $47.40 million, with the most recent change of +$26.12 million (+122.80%) on December 31, 2024.
- During the last 3 years, PTGX annual current liabilities has risen by +$3.38 million (+7.68%).
- PTGX annual current liabilities is now at all-time high.
Performance
PTGX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$35.51M+$395.00K(+1.12%)Summary
- As of today, PTGX quarterly current liabilities is $35.51 million, with the most recent change of +$395.00 thousand (+1.12%) on June 30, 2025.
- Over the past year, PTGX quarterly current liabilities has dropped by -$6.07 million (-14.60%).
- PTGX quarterly current liabilities is now -32.04% below its all-time high of $52.25 million, reached on September 30, 2017.
Performance
PTGX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PTGX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +122.8% | -14.6% |
| 3Y3 Years | +7.7% | -11.4% |
| 5Y5 Years | +33.9% | +0.4% |
PTGX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +122.8% | -25.1% | +66.9% |
| 5Y | 5-Year | at high | +122.8% | -25.1% | +66.9% |
| All-Time | All-Time | at high | +3411.0% | -32.0% | +1035.9% |
PTGX Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $35.51M(+1.1%) |
| Mar 2025 | - | $35.11M(-25.9%) |
| Dec 2024 | $47.40M(+122.8%) | $47.40M(+6.3%) |
| Sep 2024 | - | $44.58M(+7.2%) |
| Jun 2024 | - | $41.58M(+4.2%) |
| Mar 2024 | - | $39.91M(+87.6%) |
| Dec 2023 | $21.27M(-31.8%) | $21.27M(-23.7%) |
| Sep 2023 | - | $27.87M(+5.6%) |
| Jun 2023 | - | $26.40M(+13.6%) |
| Mar 2023 | - | $23.23M(-25.5%) |
| Dec 2022 | $31.18M(-29.2%) | $31.18M(-15.2%) |
| Sep 2022 | - | $36.75M(-8.3%) |
| Jun 2022 | - | $40.09M(-7.8%) |
| Mar 2022 | - | $43.46M(-1.3%) |
| Dec 2021 | $44.02M(+9.4%) | $44.02M(+12.4%) |
| Sep 2021 | - | $39.16M(-8.9%) |
| Jun 2021 | - | $42.97M(+24.5%) |
| Mar 2021 | - | $34.52M(-14.2%) |
| Dec 2020 | $40.24M | $40.24M(+4.4%) |
| Sep 2020 | - | $38.56M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $35.36M(-2.8%) |
| Mar 2020 | - | $36.37M(+2.7%) |
| Dec 2019 | $35.41M(+35.4%) | $35.41M(+15.0%) |
| Sep 2019 | - | $30.78M(-7.6%) |
| Jun 2019 | - | $33.32M(+36.0%) |
| Mar 2019 | - | $24.50M(-6.3%) |
| Dec 2018 | $26.16M(-38.5%) | $26.16M(+8.5%) |
| Sep 2018 | - | $24.10M(-16.9%) |
| Jun 2018 | - | $29.02M(-14.5%) |
| Mar 2018 | - | $33.92M(-20.3%) |
| Dec 2017 | $42.55M(+561.3%) | $42.55M(-18.6%) |
| Sep 2017 | - | $52.25M(+457.8%) |
| Jun 2017 | - | $9.37M(+20.4%) |
| Mar 2017 | - | $7.78M(+20.9%) |
| Dec 2016 | $6.43M(+105.9%) | $6.43M(+20.3%) |
| Sep 2016 | - | $5.35M(+30.1%) |
| Jun 2016 | - | $4.11M(-8.1%) |
| Mar 2016 | - | $4.47M(+43.0%) |
| Dec 2015 | $3.13M(+131.6%) | $3.13M |
| Dec 2014 | $1.35M | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual current liabilities?
- What is the all-time high annual current liabilities for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual current liabilities year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly current liabilities?
- What is the all-time high quarterly current liabilities for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly current liabilities year-on-year change?
What is Protagonist Therapeutics, Inc. annual current liabilities?
The current annual current liabilities of PTGX is $47.40M
What is the all-time high annual current liabilities for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual current liabilities is $47.40M
What is Protagonist Therapeutics, Inc. annual current liabilities year-on-year change?
Over the past year, PTGX annual current liabilities has changed by +$26.12M (+122.80%)
What is Protagonist Therapeutics, Inc. quarterly current liabilities?
The current quarterly current liabilities of PTGX is $35.51M
What is the all-time high quarterly current liabilities for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly current liabilities is $52.25M
What is Protagonist Therapeutics, Inc. quarterly current liabilities year-on-year change?
Over the past year, PTGX quarterly current liabilities has changed by -$6.07M (-14.60%)